EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Metastasis‐enhancing protein KITENIN confers temozolomide resistance on glioblastoma with unmethylated MGMT via upregulation of cancer stem cell makers

Eun-Jung Ahn, Yeong Jin Kim, Md Rashedunnabi Akanda, Se-Jeong Oh, Tae-Young Jung, Shin Jung, Jae-Hyuk Lee, Sung Sun Kim, Yong Yeon Jeong, Hyung-Ho Ha, Hoon Hyun, Hangun Kim und 4 weitere

Clinical and Translational Medicine · 2024

DOI: 10.1002/ctm2.1804 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Eun-Jung Ahn und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Chonnam National University Hwasun Hospital and Medical School, Hwasun, South Korea. Hauptthemen laut MEDLINE: Glioblastoma, Temozolomide, Neoplastic Stem Cells, DNA Modification Methylases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Chonnam National University Hospital Biomedical Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaTemozolomideNeoplastic Stem CellsDNA Modification MethylasesDNA Repair EnzymesDrug Resistance, NeoplasmUp-RegulationHumansTumor Suppressor ProteinsAntineoplastic Agents, Alkylating

Substanzen

TemozolomideMGMT protein, humanDNA Modification MethylasesDNA Repair EnzymesTumor Suppressor ProteinsAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Department of Neurosurgery, Chonnam National University Hwasun Hospital and Medical School, Hwasun, South Korea.
  • Department of Pathology, Chonnam National University Hwasun Hospital and Medical School, Hwasun, South Korea.
  • Department of Radiology, Chonnam National University Hwasun Hospital and Medical School, Hwasun, South Korea.
  • College of Pharmacy, Sunchon National University, Sunchon, South Korea.
  • Department of Biomedical Sciences, Chonnam National University Medical School, Hwasun, South Korea.
  • Medical Research Center (MRC) for Immunotherapy of Cancer, Chonnam National University Medical School, Hwasun, South Korea.

ORCID-Profile: Kyung Keun Kim, Kyung-Sub Moon

Förderung

  • National Research Foundation of Korea
  • Chonnam National University Hospital Biomedical Research Institute

Zitieren

APA

Ahn, E. J., Kim, Y. J., Akanda, M. R., Oh, S. J., Jung, T. Y., Jung, S., Lee, J. H., Kim, S. S., Jeong, Y. Y., Ha, H. H., Hyun, H., Kim, H., Rhee, J. H., Kim, K. K., Lee, K. H., & Moon, K. S. (2024). Metastasis‐enhancing protein KITENIN confers temozolomide resistance on glioblastoma with unmethylated MGMT via upregulation of cancer stem cell makers. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1804

Vancouver

Ahn EJ, Kim YJ, Akanda MR, Oh SJ, Jung TY, Jung S, et al. Metastasis‐enhancing protein KITENIN confers temozolomide resistance on glioblastoma with unmethylated MGMT via upregulation of cancer stem cell makers. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.1804

BibTeX
@article{Ahn2024,
  author = {Ahn, Eun-Jung and Kim, Yeong Jin and Akanda, Md Rashedunnabi and Oh, Se-Jeong and Jung, Tae-Young and Jung, Shin and Lee, Jae-Hyuk and Kim, Sung Sun and Jeong, Yong Yeon and Ha, Hyung-Ho and Hyun, Hoon and Kim, Hangun and Rhee, Joon Haeng and Kim, Kyung Keun and Lee, Kyung-Hwa and Moon, Kyung-Sub},
  title = {Metastasis‐enhancing protein KITENIN confers temozolomide resistance on glioblastoma with unmethylated MGMT via upregulation of cancer stem cell makers},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  doi = {10.1002/ctm2.1804}
}
Kostenlos starten →